BeBetter Med
- Biotech or pharma, therapeutic R&D
BeBetter Med, based in China, is an NDA-stage R&D company with seven clinical assets. Its US subsidiary, BeBetter Pharma, focuses on next-gen siRNA therapeutics, using proprietary platforms POCs and GDOCs, with multiple preclinical programs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}